4D pharma plc (LBPS) Social Stream
4D Pharma PLC (LBPS) Price Targets From Analysts
Use the tables below to see what analysts covering 4D Pharma PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-30 | 2 | $40 | $35 | $37.5 | $4.64 | 708.19% |
LBPS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, 4D Pharma PLC's upside potential (average analyst target price relative to current price) is higher than 99.14% of them.
- LBPS has a higher number of analysts covering the stock than 2.76% of stocks in the mid market cap category.
- 4D Pharma PLC's variance in analysts' estimates is lower than 89.96% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, 4D Pharma PLC's average analyst price target is greater than 59.18% of them.
In the Pharmaceutical Products industry, KRTX, KDNY, and ITCI are the three stocks most similar to 4D Pharma PLC regarding the price target and analyst recommendation information presented here.
What is the outlook for LBPS? Use POWR Ratings for clearer insight into price direction.